Mabel Reyes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Mabel Reyes has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Patricio Lopez-Jaramillo
Masira Research Institute, Universidad de Santander (UDES) , Bucaramanga
4 shared publications - Alba Ramírez-Sarmiento
Servicio de Neumología, Centro para el Cuidado de la Salud Respiratoria Hospital Internacional de Colombia‐Fundación Cardiovascular de Colombia FCV‐Fundación Universitaria FCV, Floridablanca, Santander, Colombia, and “EMICON” Research Group, Ministerio de Ciencia y Tecnología (MINCIENCIAS) Bogotá Colombia
2 shared publications - Alfonso Campo
Department of Epidemiology, Faculty of Medicine and Health Science, Universidad de Santander (UDES), Valledupar 200001, Colombia
2 shared publications - Allison N. Marshall
School of Health, Gerogetown University, Washington, DC 20007, USA
2 shared publications - Alvaro Castañeda-Hernandez
Instituto Masira, Facultad de Ciencias Médicas y de la Salud, Universidad de Santander, Bucaramanga, Colombia
2 shared publications - Carene Lindsay
Caribbean Institute for Health Research, The University of the West Indies, Kingston 00000, Jamaica
2 shared publications
Latest Publications
- Open Access
- 27 June 2026
- Published by Springer Nature in Pilot and Feasibility Studies
- Vol. 12 (1)
Nonpharmacological multicomponent intervention for mild cognitive impairment with a family-patient approach: protocol for the pilot clinical trial—INTERCOG study
Background: Given the risk of progression to dementia ranging from 6 to 44.8% over approximately 4 years of follow-up, nonpharmacological multicomponent interventions are emerging as promising strategies to improve or maintain cognitive function and quality of life in individuals with mild cognitive impairment (MCI). This pilot study aims to evaluate the feasibility and potential efficacy of a multicomponent and transdisciplinary intervention focused on the dyad of older adults with MCI–family study partner to promote cognitive function in older adults. Methods: A pilot, randomized, controlled, and double-blind clinical trial will be conducted with 102 dyads consisting of an older adult with MCI and their family study partner. The participants will be randomly assigned to two groups: the intervention group (INTERCOG) and the control group. The INTERCOG group will receive a 12-week home-based intervention (twice weekly) with the support of a healthcare professional. The intervention components consist of cognitive training and stimulation, nutritional counseling, and physical exercises. Simultaneously, family members will participate in a training program on care and self-care. The control group will receive an Enhanced Standard of Care with educational messages on infection prevention. The feasibility of the study will be assessed through an analysis of recruitment, data collection, intervention acceptability, and implementation challenges; also, changes in global cognition and changes in specific cognitive domains will be measured as exploratory results. Secondary outcomes will include changes in health-related quality of life, caregiver burden, social support for family members, as well as changes in functional independence, frailty, physical capacity, family functioning, and nutritional status in patients, with follow-up at 3, 6, and 9 months. In a subsample of 40 participants, the diversity of the gut microbiota will be characterized, and the frequency of the APOE-ε4 allele will be determined. Discussion: Multicomponent and transdisciplinary interventions focused on the family member–patient dyad have the potential to optimize cognitive outcomes and quality of life. This pilot study will allow us to identify key aspects of the feasibility and potential efficacy of INTERCOG intervention, crucial information for the design of future larger-scale studies. Trial registration: NCT06408103. December 6, 2024, at clinicaltrials.gov. In recruitment.
- 27 June 2026
- Published by Springer Nature in Pilot and Feasibility Studies
- Vol. 12 (1)
Open AccessNonpharmacological multicomponent intervention for mild cognitive impairment with a family-patient approach: protocol for the pilot clinical trial—INTERCOG study
Background: Given the risk of progression to dementia ranging from 6 to 44.8% over approximately 4 years of follow-up, nonpharmacological multicomponent interventions are emerging as promising strategies to improve or maintain cognitive function and quality of life in individuals with mild cognitive impairment (MCI). This pilot study aims to evaluate the feasibility and potential efficacy of a multicomponent and transdisciplinary intervention focused on the dyad of older adults with MCI–family study partner to promote cognitive function in older adults. Methods: A pilot, randomized, controlled, and double-blind clinical trial will be conducted with 102 dyads consisting of an older adult with MCI and their family study partner. The participants will be randomly assigned to two groups: the intervention group (INTERCOG) and the control group. The INTERCOG group will receive a 12-week home-based intervention (twice weekly) with the support of a healthcare professional. The intervention components consist of cognitive training and stimulation, nutritional counseling, and physical exercises. Simultaneously, family members will participate in a training program on care and self-care. The control group will receive an Enhanced Standard of Care with educational messages on infection prevention. The feasibility of the study will be assessed through an analysis of recruitment, data collection, intervention acceptability, and implementation challenges; also, changes in global cognition and changes in specific cognitive domains will be measured as exploratory results. Secondary outcomes will include changes in health-related quality of life, caregiver burden, social support for family members, as well as changes in functional independence, frailty, physical capacity, family functioning, and nutritional status in patients, with follow-up at 3, 6, and 9 months. In a subsample of 40 participants, the diversity of the gut microbiota will be characterized, and the frequency of the APOE-ε4 allele will be determined. Discussion: Multicomponent and transdisciplinary interventions focused on the family member–patient dyad have the potential to optimize cognitive outcomes and quality of life. This pilot study will allow us to identify key aspects of the feasibility and potential efficacy of INTERCOG intervention, crucial information for the design of future larger-scale studies. Trial registration: NCT06408103. December 6, 2024, at clinicaltrials.gov. In recruitment.
- Open Access
- 26 June 2026
- Published by Oxford University Press (OUP) in European Heart Journal Supplements
May Measurement Month 2023: results of an opportunistic blood pressure screening campaign in Colombia
The May Measurement Month (MMM) campaign was conducted in Colombia in 2023 to raise awareness of raised blood pressure (BP). Adults aged ≥18 years were opportunistically recruited at healthcare and public facilities across 10 sites in 10 departments. Three seated BP readings were taken on each participant, and a questionnaire collected information on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥140mmHg or diastolic BP ≥90mmHg or being on BP-lowering medication. Controlled BP was defined as being on BP-lowering medication with a BP <140/90mmHg. Multiple imputation was used to estimate missing BP readings. In total, 39,586 adults were screened, with a mean age of 45.1 years and 50.7% were female. Of all participants, 11,609 (29.3%) had hypertension, of whom 7,660 (66.0%) were aware, and 7,440 (64.1%) were on antihypertensive medication. Of those on antihypertensive medication, 5034 (67.7%) had controlled BP, and of all participants with hypertension, 43.4% had controlled BP. A pescetarian diet was significantly associated with lower systolic (−6.3mmHg, P<0.0001) and diastolic (2.2mmHg, P=0.001) BP, relative to an omnivorous diet after adjustment for age, sex, and BP-lowering medication. The MMM23 campaign in Colombia identified a substantial number of participants with undiagnosed and inadequately controlled hypertension. These findings highlight the need to keep improving awareness and to expand the implementation of proven strategies to achieve better high BP control.
- 26 June 2026
- Published by Oxford University Press (OUP) in European Heart Journal Supplements
Open AccessMay Measurement Month 2023: results of an opportunistic blood pressure screening campaign in Colombia
The May Measurement Month (MMM) campaign was conducted in Colombia in 2023 to raise awareness of raised blood pressure (BP). Adults aged ≥18 years were opportunistically recruited at healthcare and public facilities across 10 sites in 10 departments. Three seated BP readings were taken on each participant, and a questionnaire collected information on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥140mmHg or diastolic BP ≥90mmHg or being on BP-lowering medication. Controlled BP was defined as being on BP-lowering medication with a BP <140/90mmHg. Multiple imputation was used to estimate missing BP readings. In total, 39,586 adults were screened, with a mean age of 45.1 years and 50.7% were female. Of all participants, 11,609 (29.3%) had hypertension, of whom 7,660 (66.0%) were aware, and 7,440 (64.1%) were on antihypertensive medication. Of those on antihypertensive medication, 5034 (67.7%) had controlled BP, and of all participants with hypertension, 43.4% had controlled BP. A pescetarian diet was significantly associated with lower systolic (−6.3mmHg, P<0.0001) and diastolic (2.2mmHg, P=0.001) BP, relative to an omnivorous diet after adjustment for age, sex, and BP-lowering medication. The MMM23 campaign in Colombia identified a substantial number of participants with undiagnosed and inadequately controlled hypertension. These findings highlight the need to keep improving awareness and to expand the implementation of proven strategies to achieve better high BP control.
- Open Access
- 23 October 2024
- Published by Universidad de Santander - UDES in Revista Cuidarte
- Vol. 15 (3) , e3953
Knowledge on muscle strength among health professionals in Colombia: cross- sectional study
Introduction: Low muscle strength is a risk factor for various health conditions such as cardiometabolic diseases, neurodegenerative syndromes and mortality. Objective: Evaluate the knowledge of muscle strength in health professionals in Colombia. Materials and Methods: An analytical cross-sectional study was conducted in health professionals attending two continuing medical education events. Three components were evaluated through a questionnaire: identification of muscle strength as a risk factor for health conditions, measurement of muscle strength and education in muscle strength. Results: 501 participants (52.49% women) were evaluated. Of these, 53.89% (n=270) were general practitioners, 18.16% (n=91) specialists and 6.18% (n=31) nurses. The association between low muscle strength and cardiometabolic diseases was identified by 56.67% (n=153) of general practitioners and 41.94% (n=13) of nurses. The indication for measuring muscle strength in older adults was recognized by 86.81% (n=79) of specialist physicians and 41.94% (n=13) of nurses. 32.93% (n=165) of the participants were aware of some method for measurement. Physiotherapists were the group that mostly reported measuring muscle strength by 83.33% (n=20). Only 29.03% (n=9) of the nurses had received academic information on muscle strength. Discussion and Conclusions: This study demonstrates the lack of knowledge on low muscle strength, its association with health conditions and measurement methods, and the lack of information about published literature on the subject. Educational interventions are needed to incorporate muscular strength evaluation into the clinical practice.
- 23 October 2024
- Published by Universidad de Santander - UDES in Revista Cuidarte
- Vol. 15 (3) , e3953
Open AccessKnowledge on muscle strength among health professionals in Colombia: cross- sectional study
Introduction: Low muscle strength is a risk factor for various health conditions such as cardiometabolic diseases, neurodegenerative syndromes and mortality. Objective: Evaluate the knowledge of muscle strength in health professionals in Colombia. Materials and Methods: An analytical cross-sectional study was conducted in health professionals attending two continuing medical education events. Three components were evaluated through a questionnaire: identification of muscle strength as a risk factor for health conditions, measurement of muscle strength and education in muscle strength. Results: 501 participants (52.49% women) were evaluated. Of these, 53.89% (n=270) were general practitioners, 18.16% (n=91) specialists and 6.18% (n=31) nurses. The association between low muscle strength and cardiometabolic diseases was identified by 56.67% (n=153) of general practitioners and 41.94% (n=13) of nurses. The indication for measuring muscle strength in older adults was recognized by 86.81% (n=79) of specialist physicians and 41.94% (n=13) of nurses. 32.93% (n=165) of the participants were aware of some method for measurement. Physiotherapists were the group that mostly reported measuring muscle strength by 83.33% (n=20). Only 29.03% (n=9) of the nurses had received academic information on muscle strength. Discussion and Conclusions: This study demonstrates the lack of knowledge on low muscle strength, its association with health conditions and measurement methods, and the lack of information about published literature on the subject. Educational interventions are needed to incorporate muscular strength evaluation into the clinical practice.
- Open Access
- 15 October 2024
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 21 (10) , 1356
Differences in COVID-19 Vaccination and Experiences among Patients with Hypertension in Colombia and Jamaica during the COVID-19 Pandemic
During the COVID-19 pandemic, hypertensive patients had increased infection and healthcare disruption in many low- and middle-income countries (LMICs) with limited vaccine access. The objective of this report is to describe COVID-19 experiences and vaccination uptake among hypertensive patients in Colombia and Jamaica. A cross-sectional study of patients with hypertension was conducted in primary care clinics in both countries between 2021 and 2022. Trained interviewers used a telephone-administered questionnaire to assess COVID-19 experiences (infection, vaccination, and healthcare access). A total of 576 patients (68.5% female, mean age: 67.5 years) participated. Health service disruption affecting access to care was low (<10%). Compared to Jamaica, more participants from Colombia reported testing positive for COVID-19, having family members or friends testing positive, losing family members or friends due to COVID-19, and being vaccinated. In logistic regression models, adjusted for age, sex, education, and rural/urban clinic status, fear of COVID-19 (OR 2.7, 95% CI: 1.2–6.1) and residence in Colombia (OR 5.9, 95% CI: 2.4–14.6) were associated with higher vaccination uptake. Disparities in access to COVID-19 testing and diagnosis may have influenced these country differences including fear of COVID-19 and vaccine uptake. Other factors need to be better understood to prepare for future pandemic responses.
- 15 October 2024
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 21 (10) , 1356
Open AccessDifferences in COVID-19 Vaccination and Experiences among Patients with Hypertension in Colombia and Jamaica during the COVID-19 Pandemic
During the COVID-19 pandemic, hypertensive patients had increased infection and healthcare disruption in many low- and middle-income countries (LMICs) with limited vaccine access. The objective of this report is to describe COVID-19 experiences and vaccination uptake among hypertensive patients in Colombia and Jamaica. A cross-sectional study of patients with hypertension was conducted in primary care clinics in both countries between 2021 and 2022. Trained interviewers used a telephone-administered questionnaire to assess COVID-19 experiences (infection, vaccination, and healthcare access). A total of 576 patients (68.5% female, mean age: 67.5 years) participated. Health service disruption affecting access to care was low (<10%). Compared to Jamaica, more participants from Colombia reported testing positive for COVID-19, having family members or friends testing positive, losing family members or friends due to COVID-19, and being vaccinated. In logistic regression models, adjusted for age, sex, education, and rural/urban clinic status, fear of COVID-19 (OR 2.7, 95% CI: 1.2–6.1) and residence in Colombia (OR 5.9, 95% CI: 2.4–14.6) were associated with higher vaccination uptake. Disparities in access to COVID-19 testing and diagnosis may have influenced these country differences including fear of COVID-19 and vaccine uptake. Other factors need to be better understood to prepare for future pandemic responses.
- Open Access
Differences in COVID-19 Vaccination and Experiences among Patients with Hypertension in Colombia and Jamaica during the COVID-19 Pandemic
Background COVID-19 vaccination and shielding targeted hypertensive patients in low and middle income countries. We describe the COVID-19 experiences of hypertensive patients in Colombia and Jamaica and discuss factors associated with vaccine acceptance. Methods A cross-sectional study was conducted between December 2021 and February 2022 in 4 randomly selected primary care clinics in Colombia and 10 primary care clinics in Jamaica. Participants in Colombia were randomly selected from an electronic medical record. In Jamaica consecutive participants were selected on clinic days for non-communicable diseases. Interviewer-administered questionnaires were conducted by telephone. Results 576 participants were recruited (50% Jamaica; 68.5% female). Jamaica’s participants were younger (36% vs 23% Conclusion Health services disruption was low but COVID-19 experiences such as fear of COVID-19 and vaccine acceptance differed significantly between Colombia and Jamaica. Addressing reasons for these differences are important for future pandemic responses.
Open AccessDifferences in COVID-19 Vaccination and Experiences among Patients with Hypertension in Colombia and Jamaica during the COVID-19 Pandemic
Background COVID-19 vaccination and shielding targeted hypertensive patients in low and middle income countries. We describe the COVID-19 experiences of hypertensive patients in Colombia and Jamaica and discuss factors associated with vaccine acceptance. Methods A cross-sectional study was conducted between December 2021 and February 2022 in 4 randomly selected primary care clinics in Colombia and 10 primary care clinics in Jamaica. Participants in Colombia were randomly selected from an electronic medical record. In Jamaica consecutive participants were selected on clinic days for non-communicable diseases. Interviewer-administered questionnaires were conducted by telephone. Results 576 participants were recruited (50% Jamaica; 68.5% female). Jamaica’s participants were younger (36% vs 23% Conclusion Health services disruption was low but COVID-19 experiences such as fear of COVID-19 and vaccine acceptance differed significantly between Colombia and Jamaica. Addressing reasons for these differences are important for future pandemic responses.
- Open Access
- 13 October 2022
- Published by Universidad de Santander - UDES in Revista Cuidarte
- Vol. 13 (3)
Complicaciones en pacientes usuarios de traqueostomía en unidades de cuidados intensivos. Scoping Review
Introducción: Los procedimientos de traqueostomía van en aumento en las unidades de cuidados intensivos en el adulto, por lo que las complicaciones asociadas a este procedimiento también incrementan. Se ha identificado que la traqueostomía puede conllevar a complicaciones tanto preoperatorias como postoperatorias, que varían ampliamente entre un 5-40%, entre las más frecuentes están, estenosis traqueal, fístula traqueoesofágica, hemorragia, lesión peristomal, decanulación, infecciones, entre otras, que podrían causar la muerte hasta en 1,4% de las personas. Sin embargo, a nivel mundial muy pocos estudios abordan los conceptos causales o factores de riesgo mecánicos y no mecánicos de este importante tema. Objetivo: Revisar el alcance de la literatura científica disponible sobre las complicaciones de origen mecánico y no mecánico asociadas a la traqueostomía en pacientes adultos en las unidades de cuidados intensivos entre el periodo 2015-2020. Materiales y métodos: se establecieron la pregunta de investigación con metodología “Patient, Intervention, Comparation, Outcome, Time (PICOT)” y los criterios de inclusión para la búsqueda de los referentes bibliográficos de estudios observacionales y experimentales. La información fue consultada en las bases de datos PubMed y EBSCO y los artículos científicos seleccionados fueron los publicados entre los años 2015-2020. Como guía metodológica y de calidad para el presente estudio se utilizó la lista de chequeo PRISMA-ScR. Resultados: las complicaciones con mayor frecuencia son: sangrado 61% presentada (13/21 artículos), estenosis traqueal 28,5% (5/21 artículos), decanulación 23,6% (5/21 artículos), infección de la estoma 19% (4/21 artículos) muerte 19% (4/21) y la dificultad en la inserción de la cánula 19% (4/21 artículos), en cuanto a factores de riesgo mecánicos para éstas sólo se identifica el uso de la técnica Bjork flap (OR=0,4). Entre los no mecánicos se encontraron, obesidad (OR=5,15), diámetro de cánula >6 (OR= 2,6) y ventilación mecánica preoperatoria (OR=3,14). Conclusión:Se logró identificar que las complicaciones relacionadas con la traqueostomía con mayor incidencia son sangrado, estenosis traqueal, decanulación accidental y la muerte. Sin embargo, aún se desconoce si se originan por una causa mecánica o no mecánica durante su manejo en UCI. Como citar este artículo: Reyes Pulido Mabel Magoth, Orozco Levi Mauricio, Ramírez Sarmiento Alba Lucía, Nariño Gamboa Angelica Julieth, Fragozo Ibarra Andry Giseth. Complicaciones en pacientes usuarios de traqueostomía en unidades de cuidados intensivos. Scoping Review. Revista Cuidarte. 2022;13(3):e2281. http://dx.doi.org/10.15649/cuidarte.2281
- 13 October 2022
- Published by Universidad de Santander - UDES in Revista Cuidarte
- Vol. 13 (3)
Open AccessComplicaciones en pacientes usuarios de traqueostomía en unidades de cuidados intensivos. Scoping Review
Introducción: Los procedimientos de traqueostomía van en aumento en las unidades de cuidados intensivos en el adulto, por lo que las complicaciones asociadas a este procedimiento también incrementan. Se ha identificado que la traqueostomía puede conllevar a complicaciones tanto preoperatorias como postoperatorias, que varían ampliamente entre un 5-40%, entre las más frecuentes están, estenosis traqueal, fístula traqueoesofágica, hemorragia, lesión peristomal, decanulación, infecciones, entre otras, que podrían causar la muerte hasta en 1,4% de las personas. Sin embargo, a nivel mundial muy pocos estudios abordan los conceptos causales o factores de riesgo mecánicos y no mecánicos de este importante tema. Objetivo: Revisar el alcance de la literatura científica disponible sobre las complicaciones de origen mecánico y no mecánico asociadas a la traqueostomía en pacientes adultos en las unidades de cuidados intensivos entre el periodo 2015-2020. Materiales y métodos: se establecieron la pregunta de investigación con metodología “Patient, Intervention, Comparation, Outcome, Time (PICOT)” y los criterios de inclusión para la búsqueda de los referentes bibliográficos de estudios observacionales y experimentales. La información fue consultada en las bases de datos PubMed y EBSCO y los artículos científicos seleccionados fueron los publicados entre los años 2015-2020. Como guía metodológica y de calidad para el presente estudio se utilizó la lista de chequeo PRISMA-ScR. Resultados: las complicaciones con mayor frecuencia son: sangrado 61% presentada (13/21 artículos), estenosis traqueal 28,5% (5/21 artículos), decanulación 23,6% (5/21 artículos), infección de la estoma 19% (4/21 artículos) muerte 19% (4/21) y la dificultad en la inserción de la cánula 19% (4/21 artículos), en cuanto a factores de riesgo mecánicos para éstas sólo se identifica el uso de la técnica Bjork flap (OR=0,4). Entre los no mecánicos se encontraron, obesidad (OR=5,15), diámetro de cánula >6 (OR= 2,6) y ventilación mecánica preoperatoria (OR=3,14). Conclusión:Se logró identificar que las complicaciones relacionadas con la traqueostomía con mayor incidencia son sangrado, estenosis traqueal, decanulación accidental y la muerte. Sin embargo, aún se desconoce si se originan por una causa mecánica o no mecánica durante su manejo en UCI. Como citar este artículo: Reyes Pulido Mabel Magoth, Orozco Levi Mauricio, Ramírez Sarmiento Alba Lucía, Nariño Gamboa Angelica Julieth, Fragozo Ibarra Andry Giseth. Complicaciones en pacientes usuarios de traqueostomía en unidades de cuidados intensivos. Scoping Review. Revista Cuidarte. 2022;13(3):e2281. http://dx.doi.org/10.15649/cuidarte.2281
- Open Access
- 1 January 2022
- Published by Taylor & Francis in Medical Devices: Evidence and Research
- Vol. 15, 215-227
Clinical Proof of Concept for Stabilization of Tracheostomy Tubes Using Novel DYNAtraq Device
Introduction: Tracheostomy is one of the most common surgical strategies in intensive care units (ICU) and provides relevant clinical benefit for multiple indications. However, the complications associated with its use range from 5 to 40% according to different series. The risk of these complications could be reduced if fixation strategies and alignment of the tracheostomy tube with respect to the tracheal axis are improved.Aim: To build a functional device of technological innovation in respiratory medicine for the fixation and alignment of tracheostomy cannula (acronym DYNAtraq) and to evaluate its feasibility and safety in a pilot study in mechanically ventilated patients.Methods: Study carried out in four phases: (1) design engineering and functional prototyping of the device; (2) study of cytotoxicity and tolerance to the force of traction and push; (3) pilot study of feasibility and safety of its use in tracheostomized and mechanically ventilated patients; and (4) health workers satisfaction study.Results: The design of the innovative DYNAtraq device included, on the one hand, a connector with very little additional dead space to be inserted between the cannula and the ventilation tubes, and, on the other hand, a shaft with two supports for adhesion to the skin of the thorax with very high tolerance (several kilograms) to pull and push. In patients, the device corrected the malpositioned tracheostomy tubes for the latero-lateral (p < 0.001) and cephalo-caudal angles (p < 0.001). Its effect was maintained throughout the follow-up time (p < 0.001). The use of DYNAtraq did not induce serious adverse events and showed a 70% protective effect for complications (RR = 0.3, p < 0.001) in patients.Conclusion: DYNAtraq is a new device for respiratory medicine that allows the stabilization, alignment and fixation of tracheostomy tubes in mechanically ventilated patients. Its use provides additional benefits to traditional forms of support as it corrects misalignment and increases tolerance to habitual or forced movements. DYNAtraq is a safe element and can reduce the complications of tracheostomy tubes.
- 1 January 2022
- Published by Taylor & Francis in Medical Devices: Evidence and Research
- Vol. 15, 215-227
Open AccessClinical Proof of Concept for Stabilization of Tracheostomy Tubes Using Novel DYNAtraq Device
Introduction: Tracheostomy is one of the most common surgical strategies in intensive care units (ICU) and provides relevant clinical benefit for multiple indications. However, the complications associated with its use range from 5 to 40% according to different series. The risk of these complications could be reduced if fixation strategies and alignment of the tracheostomy tube with respect to the tracheal axis are improved.Aim: To build a functional device of technological innovation in respiratory medicine for the fixation and alignment of tracheostomy cannula (acronym DYNAtraq) and to evaluate its feasibility and safety in a pilot study in mechanically ventilated patients.Methods: Study carried out in four phases: (1) design engineering and functional prototyping of the device; (2) study of cytotoxicity and tolerance to the force of traction and push; (3) pilot study of feasibility and safety of its use in tracheostomized and mechanically ventilated patients; and (4) health workers satisfaction study.Results: The design of the innovative DYNAtraq device included, on the one hand, a connector with very little additional dead space to be inserted between the cannula and the ventilation tubes, and, on the other hand, a shaft with two supports for adhesion to the skin of the thorax with very high tolerance (several kilograms) to pull and push. In patients, the device corrected the malpositioned tracheostomy tubes for the latero-lateral (p < 0.001) and cephalo-caudal angles (p < 0.001). Its effect was maintained throughout the follow-up time (p < 0.001). The use of DYNAtraq did not induce serious adverse events and showed a 70% protective effect for complications (RR = 0.3, p < 0.001) in patients.Conclusion: DYNAtraq is a new device for respiratory medicine that allows the stabilization, alignment and fixation of tracheostomy tubes in mechanically ventilated patients. Its use provides additional benefits to traditional forms of support as it corrects misalignment and increases tolerance to habitual or forced movements. DYNAtraq is a safe element and can reduce the complications of tracheostomy tubes.
- Open Access
- 1 January 2021
- Published by Universidad de Manizales in Archivos de Medicina (Manizales)
- Vol. 21 (1) , 266-278
Respiratory physiotherapy in the functionality of the COVID-19 patient
The COVID-19 pandemic has wreaked great havoc on health systems globally. From respiratory physiotherapy, it tends to carry out cost-effective interventions based on the best available evidence, to minimize the functional effects in said patients with COVID-19. For this reason, the literature was reviewed to establish a theoretical review from the functionality in relation to respiratory physiotherapy in the face of the pandemic. The results included publications and management guides in Spanish, English and Portuguese about the actions of the different countries in the face of functional compromises that affect the quality of life of these patients. It was concluded that respiratory physiotherapy applies intervention protocols effects in COVID-19 for the mitigation of physical and functional complications that improve the quality of life of patients.
- 1 January 2021
- Published by Universidad de Manizales in Archivos de Medicina (Manizales)
- Vol. 21 (1) , 266-278
Open AccessRespiratory physiotherapy in the functionality of the COVID-19 patient
The COVID-19 pandemic has wreaked great havoc on health systems globally. From respiratory physiotherapy, it tends to carry out cost-effective interventions based on the best available evidence, to minimize the functional effects in said patients with COVID-19. For this reason, the literature was reviewed to establish a theoretical review from the functionality in relation to respiratory physiotherapy in the face of the pandemic. The results included publications and management guides in Spanish, English and Portuguese about the actions of the different countries in the face of functional compromises that affect the quality of life of these patients. It was concluded that respiratory physiotherapy applies intervention protocols effects in COVID-19 for the mitigation of physical and functional complications that improve the quality of life of patients.
- Open Access
- 5 December 2020
- Published by Universidad de Manizales in Archivos de Medicina (Manizales)
- Vol. 21 (2) , 598-610
Perspectivas de las intervenciones de la fisioterapia respiratoria en cuidado intensivo frente al COVID-19
La infección por COVID-19 ha afectado a la población mundial y a los sistemas de salud que le han hecho frente. No obstante, los efectos respiratorios abordados desde fisioterapia aún son inciertos. Por lo tanto, esta revisión de literatura tiene como objetivo establecer las perspectivas de las intervenciones desde la fisioterapia respiratoria en los sujetos infectados con COVID-19 donde se seleccionaron las bases de datos Pubmed, Medline, PEDro y Scielo en la búsqueda de artículos científicos y guías de manejo en idioma de inglés, portugués y español acerca de las bases moleculares y los efectos funcionales del COVID-19 sobre el sistema respiratorio. Se pudo concluir que la fisioterapia respiratoria implica un razonamiento clínico terapéutico acerca de los cambios celulares y morfológicos de los músculos respiratorios que se suscitan desde la patokinesis, intervenciones neumáticas, posicionamiento ventilatorio los cuales determinan efectos positivos en la disminución de complicaciones físicas, estancia hospitalaria y mejoría del desempeño físico y funcional.
- 5 December 2020
- Published by Universidad de Manizales in Archivos de Medicina (Manizales)
- Vol. 21 (2) , 598-610
Open AccessPerspectivas de las intervenciones de la fisioterapia respiratoria en cuidado intensivo frente al COVID-19
La infección por COVID-19 ha afectado a la población mundial y a los sistemas de salud que le han hecho frente. No obstante, los efectos respiratorios abordados desde fisioterapia aún son inciertos. Por lo tanto, esta revisión de literatura tiene como objetivo establecer las perspectivas de las intervenciones desde la fisioterapia respiratoria en los sujetos infectados con COVID-19 donde se seleccionaron las bases de datos Pubmed, Medline, PEDro y Scielo en la búsqueda de artículos científicos y guías de manejo en idioma de inglés, portugués y español acerca de las bases moleculares y los efectos funcionales del COVID-19 sobre el sistema respiratorio. Se pudo concluir que la fisioterapia respiratoria implica un razonamiento clínico terapéutico acerca de los cambios celulares y morfológicos de los músculos respiratorios que se suscitan desde la patokinesis, intervenciones neumáticas, posicionamiento ventilatorio los cuales determinan efectos positivos en la disminución de complicaciones físicas, estancia hospitalaria y mejoría del desempeño físico y funcional.